After assessing the ability of patient-specific iPSC-derived NGN2 cells to recapitulate some aspects of SMA biology, we next sought to modify and expand the CMAP platform originally focused on cancer-related immortalized cell lines to SMA NGN2 neurons (Figure 2a). The gene discussed is NEUROG2; the disease is cancer.